Literature DB >> 33497267

The Dual Burden of Type 1 Diabetes and COVID-19.

Justin M Gregory1, Daniel J Moore1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33497267      PMCID： PMC8279007          DOI： 10.7326/M21-0367

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532.

Authors:  Justin M Gregory; James C Slaughter; Sara H Duffus; T Jordan Smith; Lauren M LeStourgeon; Sarah S Jaser; Allison B McCoy; James M Luther; Erin R Giovannetti; Schafer Boeder; Jeremy H Pettus; Daniel J Moore
Journal:  Diabetes Care       Date:  2021-05       Impact factor: 19.112

Review 2.  COVID-19 in people with diabetes: understanding the reasons for worse outcomes.

Authors:  Matteo Apicella; Maria Cristina Campopiano; Michele Mantuano; Laura Mazoni; Alberto Coppelli; Stefano Del Prato
Journal:  Lancet Diabetes Endocrinol       Date:  2020-07-17       Impact factor: 32.069

3.  Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.

Authors:  Stuart J McGurnaghan; Amanda Weir; Jen Bishop; Sharon Kennedy; Luke A K Blackbourn; David A McAllister; Sharon Hutchinson; Thomas M Caparrotta; Joseph Mellor; Anita Jeyam; Joseph E O'Reilly; Sarah H Wild; Sara Hatam; Andreas Höhn; Marco Colombo; Chris Robertson; Nazir Lone; Janet Murray; Elaine Butterly; John Petrie; Brian Kennon; Rory McCrimmon; Robert Lindsay; Ewan Pearson; Naveed Sattar; John McKnight; Sam Philip; Andrew Collier; Jim McMenamin; Alison Smith-Palmer; David Goldberg; Paul M McKeigue; Helen M Colhoun
Journal:  Lancet Diabetes Endocrinol       Date:  2020-12-23       Impact factor: 32.069

4.  Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.

Authors:  Emma Barron; Chirag Bakhai; Partha Kar; Andy Weaver; Dominique Bradley; Hassan Ismail; Peter Knighton; Naomi Holman; Kamlesh Khunti; Naveed Sattar; Nicholas J Wareham; Bob Young; Jonathan Valabhji
Journal:  Lancet Diabetes Endocrinol       Date:  2020-08-13       Impact factor: 32.069

5.  Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.

Authors:  Naomi Holman; Peter Knighton; Partha Kar; Jackie O'Keefe; Matt Curley; Andy Weaver; Emma Barron; Chirag Bakhai; Kamlesh Khunti; Nicholas J Wareham; Naveed Sattar; Bob Young; Jonathan Valabhji
Journal:  Lancet Diabetes Endocrinol       Date:  2020-08-13       Impact factor: 32.069

6.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272
  6 in total
  4 in total

1.  BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report.

Authors:  Marco Infante; Andrea Fabbri; Nathalia Padilla; Francesca Pacifici; Pasquale Di Perna; Laura Vitiello; Alessandra Feraco; Maria Giuliano; Marina Passeri; Massimiliano Caprio; Camillo Ricordi; David Della-Morte; Luigi Uccioli
Journal:  Vaccines (Basel)       Date:  2022-07-08

2.  External Validation of Mortality Scores among High-Risk COVID-19 Patients: A Romanian Retrospective Study in the First Pandemic Year.

Authors:  Amanda Rădulescu; Mihaela Lupse; Alexandru Istrate; Mihai Calin; Adriana Topan; Nicholas Florin Kormos; Raul Vlad Macicasan; Violeta Briciu
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

Review 3.  COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.

Authors:  Cyril P Landstra; Eelco J P de Koning
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

Review 4.  Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529).

Authors:  Akiko Yonekawa; Nobuyuki Shimono
Journal:  Biology (Basel)       Date:  2022-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.